Jacopo Millul

Title: Jacopo Millul: Innovator in Fibroblast Activation Protein Inhibitors

Introduction

Jacopo Millul is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the development of fibroblast activation protein (FAP) inhibitors. His work focuses on innovative therapeutic and diagnostic applications that target conditions characterized by the overexpression of FAP.

Latest Patents

Jacopo Millul holds 1 patent for his invention titled "Fibroblast activation protein (FAP) inhibitors, FAP conjugates, and diagnostic and therapeutic uses thereof." This patent relates to novel FAP inhibitors and conjugates, including radiotracers, which are essential for the imaging, diagnosis, and treatment of various medical conditions.

Career Highlights

Throughout his career, Jacopo has worked with notable organizations such as Nuclidium AG and the University of Basel. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Jacopo has collaborated with esteemed colleagues, including Leila Jaafar-Thiel and Melpomeni Fani. These partnerships have enriched his research endeavors and fostered innovation in the field.

Conclusion

Jacopo Millul's work in developing FAP inhibitors showcases his dedication to advancing medical science. His innovative contributions are paving the way for new diagnostic and therapeutic strategies.